In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 18 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

Association between secondhand smoke exposure and hypertension in 131,739 Korean self-reported never-smokers verified by cotinine

Session Moderated poster session - Public health and cardiac rehabilitation

Speaker Byung Jin Kim

Event : EuroHeartCare 2019

  • Topic : preventive cardiology
  • Sub-topic : Stress, Psycho-Social and Cultural Aspects of Heart Disease
  • Session type : Moderated Posters

Authors : BJ Kim (Seoul,KR), JH Kim (Seoul,KR), DC Seo (Seoul,KR)

Authors:
BJ Kim1 , JH Kim1 , DC Seo1 , 1Division.of Cardiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine - Seoul - Korea (Republic of) ,

Citation:

Background: No study has reported the relationship between secondhand smoke (SHS) exposure and hypertension in self-reported never-smokers verified by nicotine metabolite.

Purpose: The aim of this study is to determine the relationship between SHS exposure and hypertension in self-reported and cotinine-verified never-smokers.

Methods: A total of 131,739 self-reported and cotinine-verified never-smokers (42,687 men; age 35.0±7.1 years) who participated in Kangbuk Samsung Health Study (KSHS) and Kangbuk Samsung Cohort study (KSCS) between 2011 and 2016 were included. Cotinine-verified never-smokers was defined as individuals having urinary cotinine <50 ng/mL. SHS exposure was defined as having experienced passive smoking indoors at home or the workplace.

Results: The prevalence of SHS exposure and hypertension was 22.9% and 5.9%, respectively. The prevalence of hypertension in group with SHS exposure was higher than that in group without SHS exposure (7.2% versus 5.5%, p<0.001). The multivariate regression model revealed that SHS exposure was associated with hypertension (odds ratio(OR)[95% confidence interval(CI)], 1.13[1.06, 1.21]). SHS exposure with = 1 hours/day, = 3 times/week, and = 10 years increased 13-17% for hypertension compared with no SHS exposure (1.14[1.00, 1.29], 1.13[1.03, 1.25], and 1.17[1.07, 1.28], respectively). Furthermore, SHS exposure was significantly associated with systolic blood pressure(SBP) and diastolic blood pressure(DBP) (regression coefficient[95% CI], 0.15[0.01, 0.28] for SBP and 0.18[0.07, 0.29] for DBP, all p<0.001). There was no significant gender interaction for the relationships between SHS exposure and hypertension.

Conclusion: This study showed that SHS exposure was significantly associated with hypertension in self-reported and cotinine-verified never-smokers, suggesting that necessity of health program and stricter smoking regulation to reduce the risk of hypertension.

This content is currently on FREE ACCESS, enjoy another 18 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are